» Articles » PMID: 30671282

Impact of Hyperbaric Oxygen on More Advanced Wagner Grades 3 and 4 Diabetic Foot Ulcers: Matching Therapy to Specific Wound Conditions

Overview
Date 2019 Jan 24
PMID 30671282
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this research was to identify a population of diabetic foot ulcer patients who demonstrate a significant response to hyperbaric oxygen therapy (HBOT) using a large sample size to provide guidance for clinicians when treating these complicated patients. The effect of HBOT on diabetic foot ulcers, Wagner grades 3 and 4, was evaluated using a retrospective observational real-world data set. The study reported on the overall healing rate, (74.2%) at the population level, for >2 million wounds. When a subgroup of patients of only foot ulcers with a Wagner grade 3 or 4 were considered, the healing rate was only 56.04%. The use of HBOT, without filtering for the number of treatments received, improved the healing rate to 60.01% overall. Healing rates for this same subgroup, however, were improved to 75.24% for patients who completed the prescribed number of hyperbaric treatments. This observational study discusses the importance of reporting at the population level, specific wound etiology level, a risk-stratified level, and to then overlay the effect of treatment adherence on those outcomes to provide clinicians with a comprehensive understanding of when to prescribe an advanced modality such as hyperbaric oxygen. The authors provide healing outcomes data from several prior HBOT studies as well as other advanced modalities that have been used in diabetic foot ulcer care for comparison and context.

Citing Articles

Use of the Hyperbaric Chamber Versus Conventional Treatment for the Prevention of Amputation in Chronic Diabetic Foot and the Influence on Fitting and Rehabilitation: A Systematic Review.

Apolo-Arenas M, Guerrero-Nogales L, Diaz-Munoz C, Caro-Puertolas B, Parraca J, Cana-Pino A Int J Vasc Med. 2025; 2024:8450783.

PMID: 39764384 PMC: 11703574. DOI: 10.1155/ijvm/8450783.


The effect of hyperbaric oxygen therapy on oxidative stress and inflammation in patients with diabetic foot ulcers: A preliminary study.

Perez-Vielma N, Valencia Gutierrez M, Sanchez Camacho J, Gonzalez Hernandez J, Garcia A, Ochoa C Heliyon. 2024; 10(23):e40586.

PMID: 39687107 PMC: 11647834. DOI: 10.1016/j.heliyon.2024.e40586.


Clinical Study on the treatment of chronic infectious ulcers using Platelet-Rich technology combined with moist dressings.

Zhang X, Lang Z Pak J Med Sci. 2024; 40(7):1443-1447.

PMID: 39092025 PMC: 11255822. DOI: 10.12669/pjms.40.7.8468.


Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers Based on Wagner Grading: A Systematic Review and Meta-analysis.

Oley M, Oley M, Johnson Kepel B, Faruk M, Wagiu A, Sukarno I Plast Reconstr Surg Glob Open. 2024; 12(3):e5692.

PMID: 38528847 PMC: 10962882. DOI: 10.1097/GOX.0000000000005692.


Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds.

Venkataseshan J, Viswanathan P World J Diabetes. 2022; 13(12):1122-1130.

PMID: 36578873 PMC: 9791575. DOI: 10.4239/wjd.v13.i12.1122.


References
1.
Smiell J, Wieman T, Steed D, Perry B, Sampson A, Schwab B . Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 1999; 7(5):335-46. DOI: 10.1046/j.1524-475x.1999.00335.x. View

2.
Veves A, Falanga V, Armstrong D, Sabolinski M . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001; 24(2):290-5. DOI: 10.2337/diacare.24.2.290. View

3.
. Guidance for industry: chronic cutaneous ulcer and burn wounds-developing products for treatment. Wound Repair Regen. 2001; 9(4):258-68. DOI: 10.1046/j.1524-475x.2001.00258.x. View

4.
Kalani M, Jorneskog G, Naderi N, Lind F, Brismar K . Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications. 2002; 16(2):153-8. DOI: 10.1016/s1056-8727(01)00182-9. View

5.
Armstrong D, Short B, Espensen E, Nixon B, Boulton A . Technique for fabrication of an "instant total-contact cast" for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc. 2002; 92(7):405-8. DOI: 10.7547/87507315-92-7-405. View